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     In Nagasaki area, registry of malignant tumor patients found in hospitals and 
clinics in the city has been conducted by the Nagasaki City Medical Association with the 
cooperation of Radiation Effects Research Foundation (RERF) since 1957. 
     The method of diagnosis is various such as 1) autopsy, 2) microscopy, 3) cytologic 
diagnosis, 4) endoscopic examination findings, 5) operation, 6) radiography, 7) clinical 
findings, 8) death certificate and 9) others. The number of cases collected during the 
period of 19 years up to 1975 amounts to 41,780. 
     On the other hand, tissue registry was started in September 1975. In this Registry, 
all hospitals in Nagasaki Prefecture and RERF where specimens and tissues are obtained 
and examined for diagnostic and therapeutic purposes are invited to participate. The 
purpose of the Tissue Registry is to register as many cases as possible occurring in the 
residents of Nagasaki prefecture and to promote diagnosis, treatment, early detection, 
and prevention of tumors by analyzing the collected data. 
     Prior to the establishment of the Tumor Registry, it was agreed to provide the 
best possible tissue diagnosis, clarify incidence and site of tumors, and to provide a 
central depository where useful and confirmed diagnosis are available as a source of data 
for medical studies related to tumors. 
     Fortunately, financial assistance was given to the establishment the Tissue Registry 
through RERF in accordance with a provision of the contract between the National 
Cancer Institute and the National Academy of Sciences, USA and thus the operation of 
the Tissue Registry has become available. 
     At commencement of this project, we established two sub-committees ; Pathology 
Committee and Statistics Committee.
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               PATHOLOGY COMMITTEE 
     The Tissue Registry was commenced with the neoplasm tissues of 1973. From 
among the paraffin blocks preserved at various institutions, those specimens of benign 
or malignant tumor and of the diseases of probable precancer condition are registered. 
     Microscopic specimens are stained with H-E or with special stain as required. 
Diagnosis of specimens is made by a group of four committee members. For the cases 
on which the diagnosis is not in unanimous agreement (about 3--5%), the diagnosis is 
decided at the weekly discussion meeting by all the 12 members. Those cases with 
established diagnosis are recorded in the registry card one by one.
               STATISTICS COMMITTEE 
     The procedure for coding of basic information on patients, clinical diagnosis (ICD)1) 
and histological diagnosis of tumors (ACS and SNOP)z)3), has been established. The 
work involves preparation of code sheets, coding, confirmation of the accuracy of data, 
exchange of information on exposure distance, death date, etc., with RERF. Punch 
cards and magnetic tapes of data have been prepared with the cooperation of RERF, 
and classification and statistical analysis of the registry data are being made for utiliza-
tion in research and education. 
     On the occasion of this opportunity, we wished to review the relationship between 
young Tissue Registry and almost 20 years old Tumor Registry in search of the direction 
of future activities.
                 I. TUMOR REGISTRY 
     Local cancer registry is conducted in 17 prefectures and 2 cities in Japan. 
     The method of diagnosis for the cases registered in Nagasaki City from 1957 to 
1970 was autopsy in 15.9%, microscopy and cytologic diagnosis in 34.6%, operation in 
10.0%, radiography in 9.1%, clinical diagnosis in17.9%, death certificate in 12.8%. 
     Malignant neoplasm (MN) of stomach was diagnosed by autopsy in 11.4%, mi-
croscopy and cytologic diagnosis in 26.5%, operation in 14.5%, radiography in 16. 
3 %, clinical diagnosis in 16.9%, and death certificate in 14.0%. MN of cervix uteri 
was diagnosed by autopsy in 4.7%, microscopy and cytologic diagnosis in 76.1%, ope-
ration in 4.4%, radiography in 0.1%, clinical diagnosis in 13.5%, and death certi-
ficate in 1.1%. There was a contrast between MN of stomach and cervix uteri.
Incidence and mortality of malignant neoplasms 
     1) Number of patients and incidence of malignant neoplasm by year since 1957 
     There is a tendency of gradual increase. When this is obseved by age group, the 
peak is in the age group of 60-64 for both male and female. (Table 1)
        Table 1. The Number of Patients and Incidence of Malignant Neoplasms 
                (Nagasaki City) 
Year Total 1957 1958 1959 1960 1961 1962 1963 1964 1965 
Population 7092697 321827 331080 336471 345335 350230 376048 395652 399258 407541 
Number of I 141521 435 492 515 575 590 630 617 702 813 
   Patients 
Incidence 199
.5 135.5 148.6 153.3 166.7 168.6 167.6 156.2 175.9 199.8   ( -/105 pop.) 
Year 1966 1967 1968 1969 1970 1971 1972 1973 1974 
Population 412266 417343 418970 418810 422474 425279 430338 440048 443457 
Number of 888 865 985 889 965 972 993 1124 1102 
   Patients 
Incidence 215 .5 207.4 235.6 212.7 228.7 228.7 230.9 255.5 248.8   ( -/105 pop .)
     2) The order of malignant neoplasms in incidence by sex 
     Table 2-1 & Table 2-2 shows the annual means of the incidence of malignant 
neoplasms from 1957 to 1975. Malignant neoplasm of stomach is the top in ranking for 
both male and female. 
     3) The order of malignant neoplasms in mortality by sex 
     As compared with Table 2-1 & 2-2, pancreas and esophagus are ranked higher 
for male, and the order of No.3 and No.4 is reversed for female. There are many oth-
er changes in the order of malignant neoplasms. (Table 3-1 & 3-2)
        Table 2-1. The Number of Patients and Incidence of Malignant Neoplasms 
   Male (Population 3399474) Incidence 
Order I Diagnosis No. -/105 
  1 Malignant neoplasm of stomach 2845 83.9 
  2 Malignant neoplasm of trachea, bronchus and lung 786 23.2 
  3 Malignant neoplasm of liver and intrahepatic bile ducts specified as 355 10.5          primary 
  4 Secondary malignant neoplasm of respiratory and digestive systems 346 10.2 
  5 Malignant neoplasm of rectum and rectosigmoid junction 252 7.4 
  6 Malignant neoplasm of large intestine, except rectum 238 7.0 
  7 Malignant neoplasm of pancreas 207 6.1 
  8 Malignant neoplasm of prostate 185 5.5 
   9 Lymphosarcoma and reticulum-cell sarcoma 164 4.8 
 10 Malignant neoplasm of bladder 137 4.0
        Table 2-2. The Number of Patients and Incidence of Malignant Neoplasms 
   Female (Population 3693223) Incidence 
Order I Diagnosis No. -/105 
  1 Malignant neoplasm of stomach 1930 52.3 
  2 Malignant neoplasm of cervix uteri 1160 31.4 
  3 Malignant neoplasm of breast 648 17.6 
  4 Malignant neoplasm of trachea, bronchus and lung 346 9.4 
  5 Other malignant neoplasm of uterus 256 6.9 
  6 Malignant neoplasm of thyroid gland 241 6.5 
  7 Secondary malignant neoplasm of respiratory and digestive systems 219 5.9 
  8 Malignant neoplasm of rectum and rectosigmoid junction 197 5.3 
  9 Malignant neoplasm of gall bladder and bile ducts 194 5.3 
 10 Malignant neoplasm of large intestine, except rectum 190 5.1
                     Table 3-1. The Number and Rate of Mortality 
   Male (Population 3399474) Mortality 
Order Diagnosis No. -/105 
  1 Malignant neoplasm of stomach 1999 59.0 
  2 Malignant neoplasm of trachea, bronchus and lung 651 19.2 
  3 Malignant neoplasm of liver and intrahepatic bile ducts, specified as 338 10.0          primary 
  4 Secondary malignant neoplasm of respiratory and digestive systems 289 8.5 
  5 Malignant neoplasm of pancreas 179 5.3 
  6 Malignant neoplasm of esophagus 167 4.9 
  7 Malignant neoplasm of rectum and rectosigmoid junction 166 4.9 
  8 Malignant neoplasm of large intestine, except rectum 149 4.4 
  9 Lymphosarcoma and reticulum-cell sarcoma 145 4.3 
 10 Malignant neoplasm of prostate 136 4.0
                     Table 3-2. The Number and Rate of Mortality 
   Female (Population 3693223) Mortality 
Order Diagnosis No. -/105 
  1 Malignant neoplasm of stomach 1345 36.4 
  2 Malignant neoplasm of cervix uteri 462 12.5 
  3 Malignant neoplasm of trachea, bronchus and lung 268 7.3 
  4 Malignant neoplasm of breast 208 5.6 
  5 Secondary malignant neoplasm of respiratory and digestive systems 192 5.2 
  6 Malignant neoplasm of gall bladder and bile ducts 181 4.9 
  7 Malignant neoplasm of ovary, fallopian tube and broad ligament 137 3.7 
  8 Malignant neoplasm of rectum and rectosigmoid junction 134 3.6 
  9 Malignant neoplasm of liver and intrahepatic bile ducts, specified as 112 3.0          primary 
 10 Malignant neoplasm of pancreas 111 3.0
                 II. TISSUE REGISTRY 
     Slides were prepared for 3,152 cases of tissue blocks of 1973. From these, those 
considered to be inappropriate for registry and the duplex specimens obtained from the 
same sites of the same patients were excluded, and the cases of the same tumor registered 
as primary lesion and metastasis were unified. Ultimately 2,465 cases were analyzed. 
A. Major malignant neoplasms by histological diagnosis, age and sex 
     1) Number of primary malignant neoplasms of stomach by sex, morphology and age 
     Table 4 shows the result of analysis of 210 males and 127 females. Adenocarcinoma
is in the majority and the peak is seen the 60's. 
     2) Number of primary malignant neoplasms of breast by sex, morphology and age 
     Table 5 shows the result of analysis of 1 male and 100 females. Duct carcinoma
is dominant and the peak is seen in females in the 40's. 
     3) Number of primary malignant neoplasms of cervix uteri by morphology and age 
     As a result of analysis of 194 cases as shown in Table 6, squamous cell carcinoma
is dominant and the peak is seen in the 40's and 50's. 
     4) Number of primary malignant neoplasms of lymph nodes by sex, morphology and 
         age 
     As a result of analysis of 40 males and 21 females as shown in Table 7, the 
frequency is in the order of reticullum cell sarcoma, malignant lymphoma, type unknown
    Table 4. Number of Primary Malig. of Stomach by Sex, by Morphology and by Age 
SEX I MORPHOLOGY TO AGE 
  TOTALS TAL 00- 05- 10- 15- 20- 30- 40- 50- 60- 70- 80- UN K 
M 210 Adenocarcinoma, NOS 188 6 24 33 80 33 4 8 
         Undifferentiated carcinoma 1 1 
         Papillary adenocarcinoma 6 1 1 3 1 
          Mucinous adenocarcinoma 4 1 1 1 1 
          Adenocarcinoma, signet ring 6 1 2 2 1 
          cell type 
         Medullary carcinoma 1 1 
          Adenosquamous carcinoma 1 1 
         Malignant lymphoma, NOS 1 1 
          Reticulum cell sarcoma 1 1 
         Hodgkin's disease 1 1 
F 127 Adenocarcinoma 100 2 8 14 17 36 22 1 
         Papillary adenocarcinoma 10 3 6 1 
          Mucinous adenocarcinoma 3 1 1 1 
         Adenocarcinoma, signet ring 10 2 1 3 3 " 
          cell type 
         Undifferentiated carcinoma 1 1 
          Fibrosarcoma 1 1 
          Reticulum cell sarcoma 2 1 1
and lymphosarcoma, and the occurence is frequent in the 40's to 60's though the peak 
is not definite because of the small number of cases. 
     5) Comparison of the malignancy between clinical and morphological diagnosis -1st 
        Diagnosis-
     Among the 337 cases of malignant neoplasms of stomach by histological diagnosis,
     Table 5. Number of Primary Malig. of Breast by Sex, by Morphology and by Age 
SEX MORPHOLOGY 
TO AGE 
  TOTAL TAL 00- 05- 10- 15- 20- 30- 40- 50- 60- 70- 80- UN K 
M 1` Duct arcinoma, infiltrating I 1 1 
F 100 Undifferentiated carcinoma 1 1 
         Papillary carcinoma 1 1 
          Squamous cell carcinoma 1 1
          Adenocarcinoma 
          Papillary adenocarcinoma 1 1 
         Duct carcinoma, infiltrating 91 2 9 34 22 18 3 3 
          Medullary carcinoma 2 2 
          Lobular carcinoma 2 2
   Table 6. Number of Primary Malig. of Cervix Uteri by Sex, by Morphology and by Age 
SEX MORPHOLOGY 
TO AGE 
  TOTAL TAL 00- 05- 10- 15- 20- 30- 40- 50- 60- 70- 80- UN K 
F 194 Carcinoma, in situ 2 1 1 
         Squamous cell carcinoma 182 19 47 49 33 23 4 7 
          Adenocarcinoma 3 1 1 1 
          Clear cell carcinoma 1 1 
          Adenosquamous cell carcinoma 6 2 2 1 1
  Table 7. Number of Primary Malig. of Lymph Nodes by Sex, by Morphology and by Age 
SEX MORPHOLOGY 
TO AGE 
  TOTAL TAL 00- 05- 10- 15- 20- 30- 40- 50- 60- 70- 80- UN K 
M 40 Malignant tumor 1 1 
         Malignant lymphoma, type 9 1 3 2 2 1 
            unknown 
          Lymphocytic lymphosarcoma 4 2 2 
         Lymphoblastic lymphosarcoma 4 1 1 1 1 
         Reticulum cell sarcoma 18 1 3 3 2 7 2
         Hodgkin's disease 4 3 1 
F 21 Malignant tumor 1 1 
         Malignant lymphoma, type 8 1 2 1 2 2 
             unknown 
         Lymphoblastic lymphosarcoma 3 3 
         Reticulum cell sarcoma 8 1 2 3 1 1 
          Hodgkin's disease 1 1
290 cases (86.5%) by clinical diagnosis were in agreement. Likewise, agreement was 
seen in 67 out of 101 cases of breast (66.3%), 131 out of 194 cases of cervix uteri 
(67.5%0), and 43 out of 51 cases of lymph nodes (70.5%). 
B. Relationship between Tissue Registry . and Tumor Registry 
     1) Overlapping of Tissue Registry cases with Tumor Registry cases for patients living 
        in Nagasaki City & outside of City 
     As shown in Table 8, the Tissue Registry cases of 1973 were cross-checked with 
the Tumor Registry cases of 19 years. 1,085 cases were registered in both registries 
and 1,380 cases were not in Tumor Registry. This may have resulted from the fact 
that, while Tissue Registry covered the entire prefecture for collection of specimens, 
Tumor Registry was limited to Nagasaki City and outskirts. As shown in total, 997 
unmatched cases were out of city, and additional 151 in city cases were registered.
Table 8. Overlapping of Tissue Registry Cases with Tumor Registry Cases
Tumor R. Tissue R. 
               M F I Total 
           Total In Out Unk E Total In Out Unk Total In Out Unk 
Total 881 273 445 163 1584 611 698 275 2465 884 1143 438 
Matched 398 237 65 96 687 496 81 110 1085 733 146 206 
Unmatched 483 36 380 67 897 115 617 165 1380 151 997 232 
                                                  Most of unmatched cases are out of city
            Table 9. Tumor Registry Cases 
Total in out unk total          31021 10408 351 41780
1957 990 713 4 1707 
  58 1062 741 1 1804 
  59 1160 739 2 1901 
  60 1247 780 2 2029 
  61 1291 790 3 2089 
  62 1438 693 6 2137 
  63 1618 608 5 2231 
  64 1742 565 8 2315 
  65 2011 491 10 2512 
  66 2161 416 14 2591 
  67 1893 491 21 2405 
 68 1902 539 23 2464 
 69 1738 480 15 2233 
 70 1959 471 19 2449 
 71 1927 436 25 2388 
 72 1841 420 27 2288 
 73 1928 387 104 2419 
 74 1845 353 34 2232 
 75 1268 290 28 1586
     2) Tumor Registry cases 
      As shown in Table 9, 1,700 to 2,500 cases are registered per year. 
     3) Comparison of address between Tissue Registry cases and Tumor Registry cases 
     Among the Tissue Registry cases that were also registered in Tumor registry, 
malignant tumor was found in 733 cases in city, and the address of these cases was 
compared with the residence at time of initial diagnosis in Tumor Registry. As shown 
in Table 10, only 14 cases had different address. Among the 146 cases registered as 
out of city in Tissue Registry, 20 cases were registered otherwise in Tumor Registry. 
This may be due to the difference in time of registry since Tumor Registry has been 
conducted for a long time. 
     4) Comparison of diagnosis in Tissue Registry and Tumor Registry (for agreed 
           cases) 
     Among the 1,085 cases, 63 cases (5.8%) has been diagnosed to have malignant 
and benign neoplasm in Tumor Registry but they were found to be negative in Tissue 
Registry. Malignant neoplasms were present in 12 cases involving breast in 7 cases, 
malignant lymphoma in 3 cases, prostate in 1 case and large intestine in 1 case in Tumor 
Registry. The other 51 cases were benign in Tumor Registry. 
Excluding these 63 cases, the remaining 1,022 cases were examined whether their diag-
nosis agree or disagree between the two registries. Table 11-1 shows the result. First
Table 10. Comparison of Address Between Tissue Registry Cases 
           and Tumor Registry Cases (Matched cases)
  in city in Tissue R. Out of city in Tissue R. Unk. in Tissue R. 
        Tumor Tumor Tumor 
Total In Out Unk Total In Out Unk Total In Out Unk 
733 719 10 4 146 19 126 1 206 87 34 85
Table 11-1. Comparison of Diagnosis Between Tissue Registry Cases 
                  and Tumor Registry Cases
Diag. of Tissue R. Tumor Diagnosis (1st diagnosis) 
Total Total M F 
     Agreed/Disag. 
Total 1022 799/223 390 288/102 632 511/121 
In City Total M F 
 ~. 782 623/159 287 219/ 68 495 404/ 91 
Out Total M F 
 ii 156 112/ 44 68 45/ 23 88 67/ 21 
Unk Total M F 
 ~. 84 64/ 20 35 24/ 11 49 40/ 9
diagnosis in Tumor Registry means the diagnosis by the first diagnostic method in the 
order of priority. The rate of agreement was 78.2% in total. 74.0% in male and 80.9% 
in female. 
     Then it was checked if the diagnosis in Tissue Registry agree or disagree with any 
of the first diagnosis through the third diagnosis in Tumor Registry. Table 11-2 shows 
the result. The rate of agreement is higher as a matter of course. It is 83.3% in to-
tal, 80.3% in male and 85.1% in female. 
     The diseases (ICD) of which diagnosis disagreed in over 50% of cases between the 
two registries are listed in Table 11-3.
Table 11-2. Comparison of Diagnosis Between Tissue Registry Cases 
                   and Tumor Registry Cases
 \ Diag. of Tumor Diagnosis (any diagnosis) 
 i o Total M F 
Tissue R. . 
Total Agreed/Dis. 1022 851/171 390 313/ 77 632 538/ 94 
In ii 782 667/115 287 239/ 48 495 428/ 67 
Out 'i 156 117/ 39 68 49/ 19 88 68/ 20 
Unk /i 84 67/ 17 35 25/ 10 49 42/ 7
Table 11-3. ICD of Disagreed Cases (over 50%) for 1st Diagnosis 
                                           * for any diagnosis
145. Malignant neoplasm of other and unspecified parts of mouth 
148. Malignant neoplasm of hypopharyx 
152. /i small intestine including duodenum 
171. * ii connective and other soft tissue 
195.* /i ill-defined sites 
196. * Secondary and unspecified m. n. of lymph nodes 
197.* Secondary m. n. of respiratory and digestive systems 
198.* Other secondary m. n. 
201.* Hodgkin's disease 
204. * Lymphatic leukemia 
207.* Other and unspecified leukemia 
211. Benign neoplasm of other parts of digestive system 
212. Benign neoplasm of respiratory system 
219.* Other Benign neoplasm of uterus 
221. Benign neoplasm of other female genital organs 
239.* Benign neoplasm of eye
Method of Diagnosis in Tumor Registry 
: 1. Autopsy 2. Microscopy 3. Cytologic Diagnosis 4. Endoscopic 
 Examination Findings 5. Operation 6. Radiography 7. Clinical 
 Findings 8. Death Certificates 9. Others.
     5) Method of diagnosis in cases of agreed diagnosis 
      First diagnosis in Tumor Registry by other than microscopic examination was seen 
in only 13 cases out of 799 cases as shown in Table 12-1. 
     Also, as shown in Table 12-2, any diagnosis in Tumor Registry by other than his-
tological diagnosis was seen in 15 cases out of 851 cases, 
     6) Method of diagnosis in cases of disagreed diagnosis 
     The method of diagnosis in 223 cases whose first diagnosis in Tumor Registry di-
sagreed with the diagnosis in Tissue Registry is shown in Table 13-1. Diagnosis by ot-
her than histological diagnosis was seen in 24 cases showing some increase compared with 
the previous cases. As to any diagnosis, 15 cases out of 171 cases were diagnosed by ot-
her than histological diagnosis. (Table 13-2)
            Table 12-1. Methods of diagnosis in Cases of Agreed Diagnosis 
               Method of Diagnosis on 1st Diagnosis in Tumor Registry
    Agreed Autopsy Surgical Operation X-Ray Clinical D. C. 
Total 799 49 737 7 1 3 2 
 M 288 29 253 4 1 1 
 F 511 20 484 3 2 2 
 In 623 37 578 4 1 2 1* 
Out 112 12 95 3 1 1* 
Unk 64 64 
        *184 Malignant neoplasm of other and unspecified female genital organs 
        *203 Multiple myeloma
   Table 12-2. Methods of Diagnosis in Cases of Agreed Diagnosis 
       Method of diagnosis on Any Diagnosis in Tumor Registry 
 Agreed Autopsy Surgical Operation X-Ray Clinical D.C. 
Total 851 51 785 7 1 4 3* 
 M 313 29 277 4 1 1 1 
 F 538 22 508 3 3 2 
In 667 38 619 4 1 3 2 
Out 117 13 99 3 1 1 
Unk 67 67 
3 cases of D.C.* 184 Malignant neoplasm of other and unspecified 
                     female genital organs 
                 197 Secondary malignant neoplasm of respiratory and 
                     Digestive systems 
               203 Multiple myeloma
     The fact that 1st diagnosis in 32 cases and any diagnosis in 28 cases by autopsy 
disagreed with the diagnosis in Tissue Registry is due to the difference in the site of 
tumor and the difference between primary and secondary in most cases. Complex ma-
lignant neoplasm was observed in a few cases.
 Table 13-1. Methods of Diagnosis in Cases of Disagreed Diagnosis 
         Method of Diagnosis on 1st Diag. in Tumor Registry 
 Disagreed Autopsy Surgical Operation X-Ray Clinical D.C. 
Total 223 32* 167 4 4 9 7 
 M 102 17 76 1 3 2 3 
 F 121 15 91 3 1 7 4 
In 159 27 115 2 3 7 5 
Out 44 5 32 2 1 2 2 
Unk 20 20
  * 143 m .n. of gum 
   154 m.n. of rectum and rectosigmoid junction 
    162 m.n. of trachea 
    171 m.n. of connective and other soft tissue 
   185 m.n. of prostate 
   191 m.n. of brain 
   196 Secondary and unspecified m.n. of lymph nodes 
   197 Secondary m. n. of respiratory and digestive systems 
   198 Other secondary malignant neoplasm 
   200 Lymphsarcoma and reticulum cell sarcoma 
   201 Hodgkin's disease 
   225 Benign n. of brain and other parts of nervous system 
 m. n. malignant neoplasm 
Table 13-2. Methods of Diagnosis in Cases of Disagreed Diagnosis
        Method of Diagnosis on 1st Diag. in Tumor Registry 
 Disagreed Autopsy Surgical Operation X-Ray Clinical D.C. 
Total 171 28 128 2 2 6 5 
 M 77 16 58 1 2 
 F 94 12 70 2 1 6 3 
 In 115 25 82 1 4 3 
Out 39 3 29 2 1 2 2 
Unk 17 17
     7) Frequency of malignant neoplasm 
     As shown in Table 14, the frequency of malignant neoplasm was in the order of 
stomach MN, metastatic MN of lymph nodes, malignant lymphoma in male, and MN 
of cervix uteri, MN of stomach, MN of breast in female. 
    8) Complex MN 
     Among the 2,465 cases, complication of MN and MN was observed in 3 cases and 
complication of MN and benign neoplasm in 14 cases. 
                 Table 14. Diagnosis by Sex Group of Tissue Reg. Cases 
                            (In the order of frequency of malignant neoplasms)
        Total M I F 
 1. Stomach (P-M) 331 1. Stomach (P-M) 207 1. Cervix Uteri (P-M) 178 
 2. Cervix Uteri (P-M) 178 2. Lymph Nodes (M-M) 53 2. Stomach (P-M) 124 
 3. Lymph Nodes (M-M) 102 3. Lymph Nodes (P-M) 41 3. Breast (P-M) 99 
 4. Breast (P-M) 99 4. Rectum, Rectosigmoid 39 4. Lymph Nodes (M-M) 49 
                                  junction, Anal Canal 
                               & Anus, NOS (P-M)
5. Lymph Nodes (P-M) 65 5. Skin (P-M) 35 5. Lymph Nodes (P-M) 24 
6. Rectum, Rectosigmoid 61 6. Urinary Bladder (P-M) 26 6. Connective tissue & 22 
   junction Anal Canal other soft tissue (M-M) 
   and Anus, NOS(P-M) 
7. Skin 60 7. Large Intestine (P-M) 24 7. Rectum, Rectosigmoid 22 
                                                                junction, Anal Canal 
                                                           and Anus, NOS (P-M)
8. Retroperitoneum, 43 8. Retroperitoneum (M-M) 23 8. Retroperitoneum, 20 
   Peritoneum & Intra- Peritoneum & Intra-
   abdominal sites (M-M) abdominal sites (M-M) 
9. Connective tissue & 39 9. Esophagus (P-M) 19 9. Other parts of Uterus 19 
   other soft tissue (P-M) 
   (M-M) 
10. Urinary Bladder (P-M) 33 10. Connective tissue & 17 10. Thyroid Gland & 19 
                                other soft tissue(M-M) Thyroglossal Duct 
                                                         (P-M) 
             P-M: primary malignancy M-M: metastatic malignancy
                   CONCLUSION 
     By the combined use of Tissue Registry, the criteria of diagnosis by pathologists 
can be standardized and histopathological diagnosis can be made more accurately. This 
may give a greater significance to geopathological studies. This may also provide im-
portant information for clinical diagnosis, determination of prognosis and decision of 
therapy. 
     Tumor Registry and Tissue Registry can be used for follow-up of patients and 
sometimes valuable cases can be found. Moreover, Tissue Registry serves as the library 
of neoplasm tissue specimens and these specimens are useful as educational materials.
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